Systematic Development and Optimization of Inhalable Pirfenidone Liposomes for Non-Small Cell Lung Cancer Treatment

• Ngā kaituhi matua: Vineela Parvathaneni (Author), Nishant S. Kulkarni (Author), Snehal K. Shukla (Author), Pamela T. Farrales (Author), Nitesh K. Kunda (Author), Aaron Muth (Author), Vivek Gupta (Author)
• Hōputu: Pukapuka
• I whakaputaina: MDPI AG, 2020-02-01T00:00:00Z.
• Ngā marau: article
• Urunga tuihono: Connect to this object online.

Non-small cell lung cancer (NSCLC) is a global disorder, treatment options for which remain limited with resistance development by cancer cells and off-target events being major roadblocks for current therapies. The discovery of new drug molecules remains time-consuming, expensive, and prone to fail...